PATENT CLAIM ANALYSIS

Application Number: 15899953
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "004400"]

Abstract:
The invention provides compositions including modified blood clotting factors that have a non-native proteolytic cleavage site engineered into them allowing intracellular cleavage and secretion of an active form. The compositions are useful in the methods for treating a bleeding or clotting disorder.

Claim (Index 66):
A kit comprising a composition of  claim 64 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.15789
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12823382', '14176330', '14274061', '10057620', '13932839']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7520460375720514
- 35 USC 102 Novelty (BERT): 0.5334005480392535
- Combined Prediction Score: 0.7301814886187715
- Mean Citation Score: 287.368748
- Max Citation Score: 294.18973
- Similarity Product: 108.47357440831036

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test